📰 Cellular Bone Matrix News
Cellular Bone Matrix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cellular Bone Matrix. Real-time updates on events, politics, business and more.
October 12, 2022
/PRNewswire/ -- LifeNet Health is showcasing the most advanced allograft biologics for fusion during the North American Spine Society (NASS) 2022 Annual...
June 16, 2022
Vapotherm (NYSE:VAPO – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 69.7% of Vapotherm shares are held by […]
April 13, 2022
Adynxx (OTCMKTS:ADYX – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings. Profitability This table compares Adynxx and Alphatec’s net margins, return on equity […]
April 1, 2022
NovoCure (NASDAQ:NVCR – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership. Institutional & Insider Ownership 74.5% of NovoCure shares are owned by institutional […]
March 22, 2022
/PRNewswire/ -- LifeNet Health, the world leader in allograft biologics, is showcasing its comprehensive portfolio of advanced biomaterials for fractures,...
December 29, 2020
Share this article VIRGINIA BEACH, Va., Dec. 29, 2020 /PRNewswire/ -- ViviGen ® Cellular Bone Matrix — the first cellular allograft to recover and protect viable, lineage-committed bone cells — supports outcomes that are comparable to autograft and superior to a conventional mesenchymal stem cell (MSC)-based cellular allograft in even high-risk foot and ankle procedures, according to two recent peer-reviewed publications. Foot & Ankle Specialist showed that ViviGen supports fusion even ...